Biotechnology Get all the latest news from the field of biotechnology and its many applications, including testing, treatment, and pharmaceuticals. This category includes research, clinical, and study results, as well as stories about the newest breakthroughs in the industry. Read stories about upcoming conferences and symposiums, along with releases regarding patents, legal activity, company performance, and market analysis.

Latest

Dec 06, 2017, 07:00 ET ITUS Will Present Data on Early Cancer Detection Technology at ASCO-SITC Symposium

ITUS Corporation (NASDAQ: ITUS) today announced that its abstract titled, "The coupling of MDSCs with a computational analytic method to detect...


Dec 06, 2017, 07:00 ET Nanoviricides Initiates a Safety/Toxicology Study of Its Leading Shingles Candidates

NanoViricides, Inc. (NYSE MKT: NNVC) (the "Company") reports that it has begun initial safety and toxicology evaluation of its optimized...


Dec 06, 2017, 07:00 ET Pivotal Data for Prometic's Intravenous Plasminogen Replacement Therapy to Be Presented at American Society for Hematology

- Data demonstrates that the 100% resolution of lesions present at baseline is maintained at 48 weeks LAVAL, QC, Dec. 6, 2017 /PRNewswire/...


Dec 06, 2017, 07:00 ET New Data Shows Vestagen's VESTEX® Repels Fluids and Reduces Pathogen Bioburden on the Fabric by More than 99% Compared to Conventional Scrubs

Vestagen Protective Technologies, Inc., which develops and markets VESTEX® Active Barrier1 fabric healthcare uniforms, lab coats and patient...


Dec 06, 2017, 06:30 ET TapImmune Appoints Richard Kenney, M.D., F.A.C.P., as Acting Chief Medical Officer

TapImmune Inc. (NASDAQ: TPIV), a leading clinical-stage immuno-oncology company with ongoing clinical trials in ovarian and breast cancer, today...


Dec 06, 2017, 06:15 ET Technical Perspectives on Protalix BioTherapeutics, 22nd Century, CorMedix, and iBio

In keeping with the commitment to dynamically provide members with timely information, WallStEquities.com has issued free tailored Stock Review on...


Dec 06, 2017, 05:00 ET Novasep investiert 17 Mio. Euro in „mAbulous“, eine Produktionsanlage speziell für den monoklonalen Antikörper (mAb) cGMP

Die Anlage wird die erhöhte Nachfrage nach mAb-CDMO-Services mit geringen Volumen bedienen Novasep, ein führender Anbieter von...


Dec 06, 2017, 05:00 ET Novasep Invests €17 M in "mAbulous", its Dedicated cGMP Monoclonal Antibody (mAb) Production Facility

Novasep, a leading supplier of services and technologies for the life sciences industry, announces a €17M investment in a dedicated GMP mAb...


Dec 06, 2017, 04:03 ET The Global Organ Preservation Market Is Forecasted To Grow At A CAGR Of 9.44% During The Period 2017-2021

About Organ Preservation The global organ preservation market is a part of the global organ transplantation market. Organ preservation is crucial...


Dec 06, 2017, 03:23 ET WuXi Biologics Initiated cGMP Manufacturing in the World's Largest Biologics Manufacturing Facility Using Only Single-Use Bioreactors

WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company, offering end-to-end solutions for biologics...


Dec 05, 2017, 22:11 ET Human Papillomavirus (HPV) Prophylaxis Landscape 2017

DelveInsight's 'Human PapillomaVirus (HPV) Prophylaxis Landscape, 2017' Report provides an overview of the Human PapillomaVirus (HPV) and market...


Dec 05, 2017, 22:07 ET Handheld Devices for High Viscosity Injectables

Growth in high viscosity drugs is being driven by advances in biotechnology and host-vector engineering â€" advances that have led to a steady...


Dec 05, 2017, 18:02 ET ICBII Announces the Filing of Orphan Drug Designation Application for the Use of α-Synuclein-SMART Molecule in the Treatment of Multiple System Atrophy

Innovative California Biosciences International, Inc., ("ICBII"), announced on November 20th the submission of their Orphan Drug Designation...


Dec 05, 2017, 17:39 ET Foresee Pharmaceuticals annonce les résultats d'études cliniques de phase 1

Mise en lumière du profil prometteur en termes d'innocuité, de tolérabilité et de pharmacocinétique du FP-025, inhibiteur sélectif de MMP-12....


Dec 05, 2017, 16:18 ET Viking Therapeutics Announces Proposed Public Offering of Common Stock

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...


Dec 05, 2017, 16:02 ET DNAtrix Announces First Pediatric Patient Treated with Oncolytic Virus DNX-2401

DNAtrix, a leader in the development of oncolytic virus immunotherapies for cancer, announced the intratumoral delivery of DNX-2401 to the first...


Dec 05, 2017, 13:32 ET Johnson & Johnson anuncia desenvolvimento de vacina contra o Zika

A Johnson & Johnson anuncia que a Janssen Vaccines & Prevention B.V., parte da Janssen Pharmaceutical Companies, está trabalhando em...


Dec 05, 2017, 13:00 ET PharmaForce International: Hemophilia Companies are Increasing Efforts to Target Specialized Physicians

With new products such as Genentech's Hemlibra (Emicizumab-kxwh) entering the United States marketplace, PFI interviewed personnel in critical...


Dec 05, 2017, 12:00 ET Scientists Create Successful Mass Production System for Bioengineered Livers

Researchers report creating a biologically accurate mass-production platform that overcomes major barriers to bioengineering human liver tissues...


Dec 05, 2017, 12:00 ET Genetic Rx panel on gene therapy regulatory strategies led by Renova Therapeutics CEO and Co-founder

Renova™ Therapeutics, a biotechnology company developing gene and peptide-based treatments for cardiovascular and metabolic diseases, announced...


Dec 05, 2017, 11:08 ET Foresee Pharmaceuticals anuncia los resultados de una serie de ensayos clínicos de fase I

Las conclusiones destacan las prometedoras características del FP-025, inhibidor selectivo de la MMP-12, en materia de toxicidad, tolerabilidad y...


Dec 05, 2017, 11:03 ET Bay Area Lyme Foundation Now Accepting Applications for $450,000 in Emerging Leader Award Research Grants

The Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, today announced a call for applications for three Bay Area Lyme...


Dec 05, 2017, 11:00 ET Purigen Biosystems Appoints Life Science Industry Veteran Barney Saunders, PhD, As Chief Executive Officer

Purigen Biosystems, Inc., a company providing next generation technology for extracting, enriching and quantifying nucleic acid from biological...


Dec 05, 2017, 11:00 ET Sekisui Diagnostics Enters Strategic Alliance with Mesa Biotech Inc. for Molecular POC Testing System

-- Sekisui Diagnostics becomes exclusive distributor for Mesa Biotech products in the U.S. and Canada -- Strategic alliance expands Sekisui...


Dec 05, 2017, 10:58 ET Baim Institute Names Dr. C. Michael Gibson As CEO

The Baim Institute for Clinical Research, an influential non-profit medical research institute, today named C. Michael Gibson, M.S., M.D. as its...